CDC: 1 in 3 teen girls got cervical cancer vaccine

Sep 17, 2009 By MIKE STOBBE , AP Medical Writer

(AP) -- A new government report shows one in three teenage girls have rolled up their sleeves for a relatively new vaccine against cervical cancer, but vaccination rates vary dramatically between states.

The highest rates were in Rhode Island and New Hampshire, where more than half of girls ages 13 through 17 got at least one dose of three-shot vaccination. The lowest rates were in Mississippi, Georgia and South Carolina.

The federal report is the first to give state-by-state rates for the Gardasil vaccine that targets the sexually transmitted . The report was released Thursday by the .

---

On the Net:

CDC report: http://www.cdc.gov/mmwr

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Determine patient preferences by means of conjoint analysis

add to favorites email to friend print save as pdf

Related Stories

N.H. finds voluntary vaccination works

May 13, 2007

New Hampshire says it has a winning formula for getting teenage girls vaccinated against a virus linked to cervical cancer -- make the shot voluntary.

CDC, states: US swine flu cases jump to 68

Apr 28, 2009

(AP) -- The number of confirmed swine flu cases in the United States has jumped to 64, federal officials said Tuesday, and states reported at least four more.

Recommended for you

Determine patient preferences by means of conjoint analysis

8 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments : 0